We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name DOX-SAA@LNP-PTP-DTPA, doxorubicin-self-assembled micelles loaded on lipid nanoparticles and coupled with PTP peptide and diethylenetriaminepentaacetic acid
Catalog Number R-LNP2-0323
Alias DOX-SAA@LNP-PTP peptide-DTPA
Appearance Dispersion
Molecular Formula N/A
Solubility Can be stably dispersed in aqueous solution to form a colloidal system
Storage 2-8°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application drug delivery system
Specification 10mg：Inquiry
20mg：Inquiry
50mg：Inquiry
Description DOX-SAA@LNP-PTP peptide-DTPA is a multifunctional nanodrug delivery system integrating drug loading, targeted delivery, and imaging functions. Doxorubicin (DOX), as the core anti-tumor drug, can effectively inhibit tumor cell proliferation; the composite carrier formed by self-assembled micelles (SAA) and lipid nanoparticles (LNP) has good biocompatibility and high drug-loading capacity. It can encapsulate doxorubicin, prolong the time the drug circulates in the body, and reduce the early release of the drug and the side effects on normal tissues. As a targeting molecule, PTP peptide can specifically recognize receptors on the surface of tumor cells to achieve accurate drug delivery; diethylenetriaminepentaacetic acid (DTPA) is a metal chelating agent that can chelate radionuclides or magnetic resonance imaging contrast agents, giving the system molecular imaging functions to facilitate real-time monitoring of drug distribution and treatment effects in the body.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Place the Order
FAQs
logo

Enter your email here to subscribe.

Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket